Sage Journals: Discover world-class research

Retricted access

Research article

First published 2009-06

Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria

P O’Connor, RP Kinkel, M Kremenchutzky

Multiple Sclerosis Journal

Retricted access

Research article

First published 2016-4

Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing−remitting multiple sclerosis: A retrospective analysis

E Fisher, K Nakamura, J-C Lee [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2010-5

Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study

RA Bermel, B. Weinstock-Guttman, D. Bourdette [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2007-5

Development of neutralizing antibodies to intramuscular interferon beta-1a (Avonex ®)

Suzan E. Goelz, L. Walt

Multiple Sclerosis Journal

Open access

Research article

First published 2018-12

Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE

Stanley Cohan, Ludwig Kappos, Gavin Giovannoni [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2011-3

Gender effects on intramuscular interferon beta-1a in relapsing–remitting multiple sclerosis: analysis of 1406 patients

RA Rudick, L Kappos, R Kinkel [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2017-11

No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study

Ludwig Kappos, Eva Havrdova, Gavin Giovannoni [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2017-2

Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?

Tomas Uher, Eva Havrdova, Lukas Sobisek [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2023

Pregnancy outcomes in female multiple sclerosis patients exposed to intramuscular interferon beta-1a or peginterferon beta-1a reported in a German Patient Support Programme – results from the non-interventional post-authorization safety study PRIMA

Juliane Klehmet, Yvonne Begus-Nahrmann, Kirsi Taipale [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2012-12

Intramuscular interferon beta-1a is effective in Japanese patients with relapsing–remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions

Takahiko Saida, Yasuto Itoyama, Kunio Tashiro [...]

Multiple Sclerosis Journal

Search results